新型コロナウイルス感染症治療薬・ワクチンの開発動向

抄録

In the face of the novel coronavirus infection (COVID-19), researchers and medical professionals worldwide have been tackling to develop new drug products, and regulatory authorities also have accelerated their efforts to create new schemes for the fast-track approval of drug products. This article outlines the approval systems including the newly established emergency approval system and describes the trends in the development of COVID-19 drug products and vaccines in Japan.